STERIS plc (STE) News

STERIS to Present at the Morgan Stanley Healthcare Conference

DUBLIN, IRELAND, Aug. 26, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”...

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

STERIS Announces Financial Results for Fiscal 2025 First Quarter

Total revenue from continuing operations increased 8%; constant currency organic revenue grew 6%As reported EPS...

Form 8-K - Current report

STERIS Raises Dividend to $0.57 per share

DUBLIN, IRELAND, July 31, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”...

STERIS to Host a Conference Call for Fiscal 2025 First Quarter Financial Results on August 7, 2024

DUBLIN, IRELAND, July 23, 2024 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities